Rx-360, an international pharmaceutical consortium dedicated to supply chain integrity and patient safety, is expanding its Audit Program. The primary components of this expansion include adding new audit partners, an expanded audit checklist menu, and the integration of remote auditing into the program.
 
Rx-360 is partnering with ASC Associates Ltd, blue inspection body GmbH, BSI and SQA Services, to help support the Rx-360 Audit Program.
 
Jim Fries, CEO of Rx-360 commented, “Being able to bring choice to our membership when it comes to auditing, is a valuable tool that will continue to drive our goal of reducing industry audit burden. This expansion will bring added focus to our mission around patient safety.”
 
New Services
 
Rx-360 has expanded its services to now include remote auditing. COVID-19 has changed the global environment, with that, audit needs have evolved and Rx-360 is now offering remote audits to assist the pharmaceutical industry in meeting its quality standard.
 
Rx-360 members, over the years, have developed a robust menu of checklists that the program utilizes. In 2020 Rx-360 has added audit checklists for supply chain security and single use systems.
 
Rx-360 for the last 7 years has focused their efforts on the Joint Audit Model. This program allows for industry manufacturers to confidentially join and sponsor an audit.  In return they minimize their audit costs through co-sponsorships as well as participating in the member only credit program. In 2020 Rx-360 has expanded to not only allow pharmaceutical suppliers to sponsor audits, but also promote sole sponsorships.
 
“The evolution and enhancement of the Rx-360 Audit Program increases the already tremendous value of our membership.  We look forward to continued growth now and in the future,” said Tim Valko, Rx-360 Board Chairman.